Prospective evaluation of the hybrid capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 313-316

  Halfon, Philippe ^a   Trepo, Elisabeth ^b   Antoniotti, Gilles ^c   Bernot, Catherine ^c   Cart Lamy, Philippe ^d   Khiri, Hacène ^a   Thibaud, Didier ^e   Marron, Jean ^f   Martineau, Agnès ^a   Pénaranda, Guillaume ^g   Benmoura, Dominique ^h   Blanc, Bernard ^h  

^a Laboratoire Alphabio   (France)

^b Republic Biology Center   (France)

^c Biomedica Laboratory   (France)

^d Laboratoire Clinilab   (France)

^e Laboratoire Sery   (France)

^f Clinilab Laboratory   (France)

^g CDL Pharma   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; ATYPICAL SQUAMOUS CELL OF UNCERTAIN SIGNIFICANCE; BLOTTING; CHI SQUARE TEST; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA HYBRIDIZATION; FEMALE; GENE NUMBER; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 66; INTERMETHOD COMPARISON; KAPPA STATISTICS; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MASS SCREENING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE LINE BLOT HYBRIDIZATION ASSAY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; TUMOR VIRUS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS; NUCLEOPOLYHEDROVIRUS;

EID: 33847021823     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00992-06     Document Type: Article

References (22)

1. ALTS Group. 2000. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J. Natl. Cancer Inst. 92:397-402.
2. Castle, P. E., M. Schiffman, R. Herrero, A. Hildesheim, A. C. Rodriguez, M. C. Bratti, M. E. Sherman, S. Wacholder, R. Tarone, and R. D. Burk. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J. Infect. Dis. 191: 1808-1816.
3. Castle, P. E., D. Solomon, M. Schiffman, and C. M. Wheeler. 2005. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J. Natl. Cancer Inst. 97:1066-1071.
4. Castle, P. E., C. M. Wheeler, D. Solomon, M. Schiffman, and C. L. Peyton. 2004. Interlaboratory reliability of Hybrid Capture 2. Am. J. Clin. Pathol. 122:238-245.
5. Clifford, G. M., S. Gallus, R. Herrero, N. Munoz, P. J. Snijders, S. Vaccarella, P. T. Anh, C. Ferreccio, N. T. Hieu, E. Matos, M. Molano, R. Rajkumar, G. Ronco, S. de Sanjose, H. R. Shin, S. Sukvirach, J. O. Thomas, S. Tunsakul, C. J. Meijer, and S. Franceschi. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991-998.
6. Clifford, G. M., R. K. Rana, S. Franceschi, J. S. Smith, G. Gough, and J. M. Pimenta. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14:1157-1164.
7. Clifford, G. M., J. S., Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89:101-105.
8. Davies, P., J. Kornegay, and T. Iftner. 2001. Current methods of testing for human papillomavirus. Best Pract. Res. Clin. Obstet. Gynaecol. 15:677-700.
9. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
10. Kulmala, S. M., S. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, J. Podistov, O. Ivanchenko, S. Zakharenko, R. Nerovjna, L. Kljukina, M. Branovskaja, V. Grunberga, A. Juschenko, P. Tosi, R. Santopietro, and K. Syrjanen. 2004. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J. Clin. Microbiol. 42:2470-2475.
11. Lörincz, A., and J. Anthony. 2001. Advances in HPV detection by hybrid capture. Papillomavir. Rep. 12:145-154.
12. Mendez, F., N. Munoz, H. Posso, M. Molano, V. Moreno, A. J. van den Brule, M. Ronderos, C. Meijer, and A. Munoz. 2005. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192:1158-1165.
13. Monsonego, J., J. M. Bohbot, G. Pollini, C. Krawec, C. Vincent, I. Merignargues, F. Haroun, P. Sednaoui, L. Monfort, R. Dachez, and K. Syrjanen. 2005. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal Pap smear. Gynecol. Oncol. 99:160-168.
14. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
15. Perrons, C., R. Jelley, B. Kleter, W. Quint, and N. Brink. 2005. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32:278-285.
16. Peyton, C. L., M. Schiffman, A. T. Lorincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriguez, R. Herrero, M. E. Sherman, and C. M. Wheeler. 1998. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:3248-3254.
17. Poljak, M., K. Fujs, K. Seme, B. J. Kocjan, and E. Vrtacnik-Bokal. 2005. Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples. Acta Dermatovenerol. Alp. Panonica Adriat. 14:147-152.
18. Smith, R. A., V. Cokkinides, and H. J. Eyre. 2003. American Cancer Society guidelines for the early detection of cancer. CA Cancer J. Clin. 53:27-43.
19. Snijders, P. J., A. J. van den Brule, and C. J. Meijer. 2003. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6.
20. van Ham, M. A., J. M. Bakkers, G. K. Harbers, W. G. Quint, L. F. Massuger, and W. J. Melchers. 2005. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J. Clin. Microbiol. 43:2662-2667.
21. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J. Pathol. 189:12-19.
22. Wright, T. C. J., J. Cox, L. Massad, L. Twiggs, E. Wilkinson, et al. 2002. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120-2129.